Healthcare providers coast to coast invest in the company’s EHR-integrated point-of-care patient engagement solution to drive improved health outcomes.
Leading-edge technology solutions supporting wellness to be exhibited at HIMSS 2019.
Yardley, PA (February 6, 2019) — StayWell, a health empowerment company, today announced several leading health system partners have contracted to offer Krames On FHIR®. Using SMART On FHIR® technologies, the application integrates directly into the health system’s electronic health record (EHR) and seamlessly into the clinician’s workflow. Its connectivity enables access to award-winning patient education tools at the point of care based on the patient’s health condition, medical visit, language and literacy level. The company will be spotlighting Krames On FHIR, among other new health and wellness innovations, such as the StayWell VR Meditation app, in booth 1715 at the HIMSS19 Global Conference & Exhibition, February 11-15 in Orlando, Fla.
“With the continued growth of our partnerships, we’re thrilled to experience first-hand how Krames On FHIR is positively impacting providers and patients alike,” said Nicole Latimer, StayWell CEO. “Industry research shows that health literacy is directly tied to health outcomes. Leveraging Krames On FHIR, providers now can instantly access and share the most up-to-date personalized health information — from printable handouts to videos and other digital content — in an easy-to-understand format, designed to not only improve patient comprehension, but to also assess how patients are utilizing the information to better meet their needs and ensure the best possible outcomes.”
Recent StayWell Krames On FHIR partners include: Baystate Health; CoxHealth; Houston Methodist Health System; Nebraska Medicine; North Mississippi Health Services; Oklahoma Heart Hospital; and Saint Luke's Health System (Kansas City, Mo.).
“Because it’s built on advanced SMART On FHIR technology, the Krames On FHIR application updates in real time, without any additional installation necessary by our IT department,” said Louis Krenn, MD, chief medical information officer and a family practice physician at CoxHealth in Springfield, Mo. “Krames On FHIR gives me added confidence to know that I'm providing my patients with quality, up-to-date patient education content, and it allows me to efficiently deliver that content in the language and format that meets my patients’ needs, whether it be a paper printout or sent directly to them through their patient portal.”
Krames On FHIR key features and benefits include:
- EHR integration and access – Fast and flexible delivery solution built right into the clinician’s existing workflow, with no extra login required, makes finding and sharing educational content simple.
- Customizable content – Suggested educational materials with the ability to personalize by age, gender and native language support patient comprehension while meeting Meaningful Use requirements.
- Boosted resource efficiency – User-friendly technology with automatic updates saves IT departments up to 30 hours per quarter while keeping content up to date. No more monthly IT uploads.
- Increased continuity of care – Enables clinicians to monitor educational tools and videos accessed by patients to glean actionable insights and follow-up as necessary.
“With Krames on FHIR, we’re providing educational resources that help our patients be more informed and better prepared. This can aid in their recovery, and for inpatients, also may help decrease readmissions,” said Janet Leatherwood, chief nursing officer at Houston Methodist Sugar Land.
At HIMSS19, booth 1715, StayWell will feature captivating presentations and demonstrations of the company’s technology solutions focusing on clinical and mobile patient engagement. Visitors will hear about the benefits and adoption of SMART on FHIR, along with live demos of the MyStayWell platform and Krames On FHIR app. Join the conversation online with #StayWellonFHIR and schedule a meeting with a team member here.
In addition, continued enhancements to Krames On FHIR for the provider and payer markets, including integration with new EHR workflows — care planning and population health — will be available in 2019. Additional features will include a patient engagement dashboard with an interactive questionnaire designed to continually monitor patient progress and usage of shared educational resources. This actionable insight will enable providers to make more informed and timely treatment modifications.
Learn more about Krames On FHIR and how StayWell is lighting the path to better patient education here.
About Krames On FHIR®
Krames On FHIR® is a game-changing app and solution suite from StayWell. It delivers award-winning Krames Patient Education to clinicians and patients at the point of care, where it has the best chance of improving patient outcomes. Using SMART on FHIR technologies, Krames On FHIR integrates seamlessly into a health system’s EHR and directly into the clinician’s workflow. It enables clinicians to “prescribe” digital, video, and even printed educational content based on the patient’s profile and current clinical encounter. The solution’s new functionalities increase the amount of information shared between clinicians and patients – yet they reduce the annoyances caused by additional apps, logins and workflows. For patients, the educational materials appear in their view of the EHR’s patient portal. Healthcare providers now have transparency to see exactly which resources patients have accessed, which improves patient-physician communication and compliance with care recommendations.
StayWell is a health empowerment company that enables populations to improve health outcomes through the science of behavior change. For more than 40 years, the company has been a pioneer in employer well-being and patient education solutions that lower risks and reduce costs. StayWell has earned numerous top industry honors for its population health programs, including the C. Everett Koop National Health Award and the Web Health Award. The company has also received Utilization Review Accreditation Committee (URAC) and National Committee for Quality Assurance (NCQA) accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc. The company is headquartered in Yardley, Pa., with additional locations including St. Paul, Minn.; Portland, Ore.; and Atlanta. To learn more, visit www.staywell.com or connect with StayWell on Twitter, Facebook or LinkedIn.
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, YouTube and LinkedIn.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of The StayWell Company, a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2017 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
About Vestar Capital Partners
Vestar Capital Partners is a leading U.S. middle-market private equity firm specializing in management buyouts and growth capital investments. Vestar invests and collaborates with incumbent management teams and private owners to build long-term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products. Since its founding in 1988, Vestar funds have completed more than 80 investments in companies – as well as more than 200 add-on acquisitions – with a total value of approximately $50 billion. For more information, please visit www.vestarcapital.com.
Media contact / Melissa Gilkerson / 612-599-5157 / email@example.com